Nigel Paneth is trained in Pediatrics and in Epidemiology and founded the MSU Department of Epidemiology and Biostatistics in the College of Human Medicine in 1998. His interests are largely in the effects of events in pregnancy and around the time of birth on the health and development of children, but since March he has been a member of the National Convalescent Plasma COVID-19 Project (CCPP-19) leadership team.
 
CCPP-19 is a coalition of physician-scientists from across the country who investigate the role of convalescent plasma and other passive immunization techniques on outcomes in COVID-19 disease. MSU participates in the analysis of the data recorded in the registry of 85,000 patients transfused with convalescent plasma located at the Mayo Clinic and set up by the FDA Expanded Access Program for Convalescent Plasma in early April. Results of some of those analyses will be described as well as the findings of other studies of convalescent plasma. He will also discuss other passive immunization strategies being developed including the monoclonal antibodies currently under development that were used in the treatment of President Trump.